(Q40140668)

English

Prostate cancer gene 3 and multiparametric magnetic resonance can reduce unnecessary biopsies: decision curve analysis to evaluate predictive models

scientific article published on 29 September 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 September 2017

Prostate cancer gene 3 and multiparametric magnetic resonance can reduce unnecessary biopsies: decision curve analysis to evaluate predictive models (English)

1 reference

Europe PubMed Central

17 September 2017

Gian Maria Busetto

1

1 reference

Europe PubMed Central

17 September 2017

Ettore De Berardinis

2

1 reference

Europe PubMed Central

17 September 2017

Alessandro Sciarra

3

1 reference

Europe PubMed Central

17 September 2017

6

1 reference

Europe PubMed Central

17 September 2017

7

1 reference

Europe PubMed Central

17 September 2017

Vincenzo Gentile

9

1 reference

Europe PubMed Central

17 September 2017

author name string

Valeria Panebianco

4

1 reference

Europe PubMed Central

17 September 2017

Riccardo Giovannone

5

1 reference

Europe PubMed Central

17 September 2017

Franco Di Silverio

8

1 reference

Europe PubMed Central

17 September 2017

Stefano Salciccia

10

1 reference

Europe PubMed Central

17 September 2017

language of work or name

0 references

publication date

29 September 2013

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

82

1 reference

Europe PubMed Central

17 September 2017

1355-1360

1 reference

Europe PubMed Central

17 September 2017

6

1 reference

Europe PubMed Central

17 September 2017

Emerging biomarkers for the diagnosis and prognosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Use of PCA3 in detecting prostate cancer in initial and repeat prostate biopsy patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Assessment of the PCA3 test for prostate cancer diagnosis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Optimizing performance and interpretation of prostate biopsy: a critical analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Rational approach to implementation of prostate cancer antigen 3 into clinical care

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Optimising repeat prostate biopsy decisions and procedures

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Advances in magnetic resonance imaging: how they are changing the management of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Biopsy-Derived Gleason Artifact and Prostate Volume: Experience Using Ten Samples in Larger Prostates

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Decision curve analysis: a novel method for evaluating prediction models

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Improvements in ability to detect undiagnosed diabetes by using information on family history among adults in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Performance of prostate cancer antigen 3 (PCA3) and prostate-specific antigen in Prescreened men: reproducibility and detection characteristics for prostate cancer patients with high PCA3 scores (≥ 100).

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Prostate cancer gene 3 (PCA3): development and internal validation of a novel biopsy nomogram.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Prostate cancer detection in the "grey area" of prostate-specific antigen below 10 ng/ml: head-to-head comparison of the updated PCPT calculator and Chun's nomogram, two risk estimators incorporating prostate cancer antigen 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2013.06.078

7 January 2021

Identifiers

10.1016/J.UROLOGY.2013.06.078

1 reference

Europe PubMed Central

17 September 2017

1 reference

Europe PubMed Central

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40140668&oldid=1886740811"